Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikkel Werling

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Perspectives on Psychological Science : a Journal of the Association for Psychological Science|June 27, 2023
Maintaining Transient Diversity Is a General Principle for Improving Collective Problem SolvingPaul E Smaldino, Cody Moser, Alejandro Pérez Velilla, et al.
Hemasphere|April 16, 2026
Machine learning enhances risk stratification and treatment failure prediction in diffuse large B-cell lymphomaMikkel Werling, Alexander D Fuglkjær, Peter Brown, et al.
Blood Advances|May 13, 2026
Rituximab maintenance after first-line rituximab-bendamustineChristian Brieghel, Mikkel Werling, Peter de Nully Brown, et al.
Acta Oncologica (Stockholm, Sweden)|February 19, 2026
Post-treatment infection prediction in CLL using domain adaptation of lymphoma electronic health recordsMehdi Parviz, Christian Brieghel, Mikkel Werling, et al.
Hemasphere|July 17, 2025
Polypharmacy independently predicts survival, hospitalization, and infections in patients with lymphoid cancerChristian Brieghel, Thomas Lacoppidan, Esben Packness, et al.
British Journal of Haematology|July 1, 2026
Effects of chronic lymphocytic leukaemia (CLL)-directed therapy on diffuse large B-cell lymphoma (DLBCL) type Richter transformation compared to de novo DLBCL in a nationwide cohortAndreas Katsimigas, Mikkel Werling, Casper M Frederiksen, et al.
Clinical Epidemiology|February 25, 2025
The Danish Lymphoid Cancer Research (DALY-CARE) Data Resource: The Basis for Developing Data-Driven HematologyChristian Brieghel, Mikkel Werling, Casper Møller Frederiksen, et al.
European Journal of Haematology|July 29, 2025
Machine Learning for Prediction of High-Risk Hospitalizations in Lymphoma Patients: A Danish Population-Based StudyAlexander Djupnes Fuglkjaer, Deniz Kenan Kilic, Mathias Holmsgaard Eskesen, et al.
Npj Aging|June 9, 2026
Disentangling shifting demographic and treatment effects on years of life lost to cancer in DenmarkÓlafur Birgir Davíðsson, Emelie Hamotal Curovic-Rotbain, Ragnar Pétur Kristjánsson, et al.
Blood Neoplasia|April 30, 2026
CD20 negativity at the start of second-line therapy predicts a shorter overall survival in B-cell lymphomasSanaz Mehdi Gholy, Torgerð Ranadóttir, Olafur Birgir Davidsson, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Perspectives on Psychological Science : a Journal of the Association for Psychological Science|June 27, 2023
Maintaining Transient Diversity Is a General Principle for Improving Collective Problem SolvingPaul E Smaldino, Cody Moser, Alejandro Pérez Velilla, et al.
Hemasphere|April 16, 2026
Machine learning enhances risk stratification and treatment failure prediction in diffuse large B-cell lymphomaMikkel Werling, Alexander D Fuglkjær, Peter Brown, et al.
Blood Advances|May 13, 2026
Rituximab maintenance after first-line rituximab-bendamustineChristian Brieghel, Mikkel Werling, Peter de Nully Brown, et al.
Acta Oncologica (Stockholm, Sweden)|February 19, 2026
Post-treatment infection prediction in CLL using domain adaptation of lymphoma electronic health recordsMehdi Parviz, Christian Brieghel, Mikkel Werling, et al.
Hemasphere|July 17, 2025
Polypharmacy independently predicts survival, hospitalization, and infections in patients with lymphoid cancerChristian Brieghel, Thomas Lacoppidan, Esben Packness, et al.
British Journal of Haematology|July 1, 2026
Effects of chronic lymphocytic leukaemia (CLL)-directed therapy on diffuse large B-cell lymphoma (DLBCL) type Richter transformation compared to de novo DLBCL in a nationwide cohortAndreas Katsimigas, Mikkel Werling, Casper M Frederiksen, et al.
Clinical Epidemiology|February 25, 2025
The Danish Lymphoid Cancer Research (DALY-CARE) Data Resource: The Basis for Developing Data-Driven HematologyChristian Brieghel, Mikkel Werling, Casper Møller Frederiksen, et al.
European Journal of Haematology|July 29, 2025
Machine Learning for Prediction of High-Risk Hospitalizations in Lymphoma Patients: A Danish Population-Based StudyAlexander Djupnes Fuglkjaer, Deniz Kenan Kilic, Mathias Holmsgaard Eskesen, et al.
Npj Aging|June 9, 2026
Disentangling shifting demographic and treatment effects on years of life lost to cancer in DenmarkÓlafur Birgir Davíðsson, Emelie Hamotal Curovic-Rotbain, Ragnar Pétur Kristjánsson, et al.
Blood Neoplasia|April 30, 2026
CD20 negativity at the start of second-line therapy predicts a shorter overall survival in B-cell lymphomasSanaz Mehdi Gholy, Torgerð Ranadóttir, Olafur Birgir Davidsson, et al.
Pageof 1